- Acne
- Actinic Keratosis
- Aesthetics
- Alopecia
- Atopic Dermatitis
- Buy-and-Bill
- COVID-19
- Case-Based Roundtable
- Chronic Hand Eczema
- Drug Watch
- Eczema
- General Dermatology
- Hidradenitis Suppurativa
- Melasma
- NP and PA
- Pediatric Dermatology
- Pigmentary Disorders
- Practice Management
- Precision Medicine and Biologics
- Prurigo Nodularis
- Psoriasis
- Psoriatic Arthritis
- Rare Disease
- Rosacea
- Skin Cancer
- Vitiligo
- Wound Care
Article
Pointers With Portela: What to Know About Mohs Surgery
Author(s):
In this week’s Pointers with Dr Portela, the 208SkinDoc discusses basal cell carcinoma and Mohs surgery related to Jill Biden's most recent skin cancer diagnosis.
Dustin Portela, DO, a board-certified dermatologist and dermatologic surgeon at Treasure Valley Dermatology in Boise, Idaho, reviews the recent news of Jill Biden's basal cell carcinoma diagnosis. Portela explains how Mohs surgery is used to treat skin cancer lesions, and how the procedure damages as little tissue as possible.
Opinions expressed are that of Portela and do not express the views or opinions of Dermatology Times®.
Related Videos
Apoptosis-Based Skin Cancer Treatment Shows Promise
Mastering Dermoscopy and Dysplastic Nevi
The Future of AI in Dermatology with Andy Beck, MD, PhD
How PathAI’s PathAssist Derm Tool Aims to Enhance Skin Cancer Diagnosis and Workflow Efficiency
Expanding Collaborations in the Fight Against Skin Cancer
Spearheading Awareness Campaigns for Skin Cancer Prevention and Sun Protection
Resources for Patients and Clinicians from the Skin Cancer Foundation
2025 Goals and Priorities of The Skin Cancer Foundation: An Interview with Executive Director, Becky Kamowitz
Data Review of 2 doses of Sonidegib in Advanced Basal Cell Carcinoma (BOLT Trial)
Expert Perspectives on EVRIANCE clinical trial data
Related Content
